Would you have Dysphonia when you have Cystic Fibrosis?

Summary

Dysphonia is found among people with Cystic fibrosis, especially for people who are female, 10-19 old, take medication Tobi and have Pain. We study 36 people who have Dysphonia and Cystic fibrosis from FDA and social media. Find out below who they are, other conditions they have and drugs they take.

You are not alone

Join a support group for people who have Cystic fibrosis and Dysphonia >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Cystic Fibrosis

Cystic fibrosis (disease of the secretary glands) can be treated by Ceftazidime, Tobramycin, Pulmozyme, Meropenem, Cayston (latest reports from 2,890 Cystic fibrosis patients)

Dysphonia

Dysphonia (speech disorder attributable to a disorder of phonation) has been reported by people with tendon rupture, indigestion, drowsiness, diarrhea, psychotic disorder (latest reports from 17,742 Dysphonia patients).

On Aug, 31, 2016

36 people who have Cystic Fibrosis and Dysphonia are studied.


Number of reports submitted per year:

Would you have Dysphonia when you have Cystic fibrosis?

Gender of people who have Cystic Fibrosis and experience Dysphonia *:

  • female: 61.11 %
  • male: 38.89 %

Age of people who have Cystic Fibrosis and experience Dysphonia *:

  • 0-1: 0.0 %
  • 2-9: 4.55 %
  • 10-19: 27.27 %
  • 20-29: 22.73 %
  • 30-39: 9.09 %
  • 40-49: 9.09 %
  • 50-59: 4.55 %
  • 60+: 22.73 %

Top co-existing conditions for these people *:

  • Pain (5 people, 13.89%)
  • Lung Disorder (4 people, 11.11%)
  • Pseudomonas Infection (3 people, 8.33%)
  • Pancreatic Insufficiency (3 people, 8.33%)
  • Gastrooesophageal Reflux Disease (3 people, 8.33%)
  • Cystic Fibrosis Lung (2 people, 5.56%)
  • Pneumonia (1 person, 2.78%)
  • Diabetes Mellitus (1 person, 2.78%)
  • Attention Deficit/hyperactivity Disorder (1 person, 2.78%)

Most common drugs for these people *:

  • Tobi (24 people, 66.67%)
  • Pulmozyme (22 people, 61.11%)
  • Albuterol (14 people, 38.89%)
  • Creon (12 people, 33.33%)
  • Tobi Podhaler (9 people, 25.00%)
  • Omeprazole (8 people, 22.22%)
  • Advair Diskus 100/50 (8 people, 22.22%)
  • Spiriva (6 people, 16.67%)
  • Singulair (5 people, 13.89%)
  • Prilosec (4 people, 11.11%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Dysphonia and Cystic fibrosis?

Browse all symptoms of Cystic fibrosis

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Dysphonia

Dysphonia

Other conditions that could case Dysphonia

Dysphonia

Can you answer these questions?

More questions for: Cystic fibrosis, Dysphonia

You may be interested in these reviews

More reviews for: Cystic fibrosis, Dysphonia


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.